Colfax Corporation, a technology company, announced the future composition of the board of directors, which will be renamed Enovis Corporation upon the completion of the company’s previously announced spin-off of its existing welding and fabrication technology business, which will operate as ESAB Corporation.
The spin-off is slated to occur in April.
Publicly traded Colfax is based in Little Falls, west of Wilmington. In 2021, the company relocated its headquarters from Annapolis Junction, MD. Enovis will be based in Delaware, with ESAB headquartered in Maryland.
Following the separation, Mitchell P. Rales will continue to serve as board chairman, and current Colfax directors Liam Kelly, Philip Okala, Clayton Perfall, Rajiv Vinnakota, Sharon Wienbar, and Matt Trerotola will remain in their current roles as directors of Enovis. Trerotola will also serve as CEO of Enovis upon completion of the separation.
In addition, the board has appointed Barbara Bodem, Angela S. Lalor, Dr. Christine Ortiz, and Brady R. Shirley to serve as directors of the company, effective upon the consummation of the separation.
Bodem served as Senior Vice President and CFO at Hillrom, a global medical technology company, from 2018 until its acquisition by Baxter International Inc. in 2021.
Lalor has been senior vice president, human resources of Danaher Corporation since 2012, and will be moving into an advisory role at Danaher as of April 1, 2022, until her planned retirement in the first quarter of 2023.
Dr. Ortiz is the Morris Cohen Professor of Materials Science and Engineering at the Massachusetts Institute of Technology. She has made pioneering advancements in biotechnology, biomaterials, and nanotechnology.
Shirley was appointed as CEO of the Company’s DJO business in November 2016. Before that, he served as the President of the DJO Surgical business, a position he was appointed to in March of 2014. From 2009 to 2013, Shirley was the CEO and a director of Innovative Medical Device Solutions, a company that provides comprehensive product development, manufacturing, and supply chain management solutions for medical device companies within the orthopedic medical device industry.
The company also announced that current Colfax directors Patrick W. Allender, Rhonda L. Jordan, and Didier Teirlinck will be resigning from the board effective upon the consummation of the separation to join the board of directors of ESAB Corporation and that Thomas M. Gayner has announced his intention to retire from the board effective as of March 31, 2022.
“I’m confident that Enovis will become one of the world’s leading medical technology companies with the guidance of this diverse, experienced, and passionate board of directors,” said Trerotola. “The Enovis Board will bring a wealth of knowledge in healthcare, technology, strategic growth,
